What is the IV infusion titration for a 92kg patient receiving 36.4 grams of Intravenous Immunoglobulin (IVIG) in a 364mL solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IVIG Infusion Titration Protocol for 92kg Patient Receiving 36.4g (364mL)

For this 92kg patient receiving 36.4 grams of IVIG, administer the infusion over 4-6 hours for the first dose, starting at a slow rate and gradually increasing as tolerated, with subsequent doses potentially given over 2-4 hours if well-tolerated. 1

Pre-Infusion Preparation

Premedication:

  • Administer diphenhydramine 1 mg/kg (approximately 92mg for this patient) 1
  • Administer acetaminophen 10-15 mg/kg (approximately 920-1380mg for this patient) 1
  • Consider corticosteroids if the patient has a history of infusion reactions 2

Pre-Assessment:

  • Check baseline vital signs before starting 1
  • Ensure adequate hydration 1
  • Verify IgA levels have been checked to prevent severe anaphylaxis in IgA-deficient patients 2, 1
  • Review renal function, as monitoring is required during administration 2

Infusion Rate Titration

Initial Infusion (First Dose):

  • Start slowly: Begin at 0.5-1 mL/kg/hour (46-92 mL/hour for this 92kg patient) for the first 30 minutes 3
  • Gradual increase: If tolerated without adverse reactions, increase by 0.5 mL/kg/hour every 15-30 minutes 3
  • Target rate: Work up to a maximum of 3-4 mL/kg/hour (276-368 mL/hour) as tolerated 3
  • Total duration: Complete the 364mL infusion over 4-6 hours 1

Subsequent Infusions:

  • If the first infusion was well-tolerated, subsequent doses may be administered over 2-4 hours 1
  • Use the same gradual titration approach but may reach target rate more quickly 1

Monitoring Protocol

Vital Sign Monitoring:

  • Check vitals every 15-30 minutes during the first hour 1
  • Check hourly thereafter if stable 1
  • Monitor continuously for signs of adverse reactions 3

Parameters to Monitor:

  • Blood pressure, heart rate, respiratory rate, temperature 1
  • Renal function including urine output and serum creatinine 2
  • Signs of fluid overload, particularly in patients with cardiac dysfunction 2

Management of Adverse Reactions

If Mild Reactions Occur (flushing, headache, malaise):

  • Slow or temporarily stop the infusion 3
  • Administer additional antihistamines or acetaminophen 3
  • Resume at a slower rate once symptoms resolve 3

If Severe Reactions Occur (anaphylaxis, severe hypotension):

  • Immediately stop the infusion 2
  • Administer epinephrine 2
  • Notify physician immediately 2

Important Clinical Caveats

  • Do not administer plasmapheresis immediately after IVIG, as it will remove the immunoglobulin 1
  • Patients with cardiac dysfunction may benefit from divided dosing (splitting the dose over 2 days at 1 g/kg daily) to minimize fluid overload 2
  • The majority of adverse effects are transient and mild, but rare serious complications include renal impairment, thrombosis, and hemolytic anemia 3
  • Infusing at a slow rate and premedicating can minimize adverse effects 3

References

Guideline

IVIG Infusion Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intravenous Immunoglobulin Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adverse Effects of Immunoglobulin Therapy.

Frontiers in immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.